Veru Inc.: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 8, 2025 and accepted by EDGAR at May 8, 2025, 11:51 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $0 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2025-01-01 to 2025-03-31 | $3.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2024-10-01 to 2025-03-31 | $9.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-31 | $5.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2024-10-01 to 2025-03-31 | $10.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | −$8.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-10-01 to 2025-03-31 | −$18.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-01-01 to 2025-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-10-01 to 2025-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$7.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-10-01 to 2025-03-31 | −$16.8m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-10-01 to 2025-03-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 6 months2024-10-01 to 2025-03-31 | −$19.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-10-01 to 2025-03-31 | $1.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-03-31 | $20.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $21.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $32.7m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $5.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $11.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-31 | $21.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-25-015330. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.